{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:31:50Z","timestamp":1795134710882,"version":"4.10.3"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate the effect of cataract extraction (CE) by phacoemulsification on the vitreomacular interface (VMI) of eyes with preexisting vitreomacular traction (VMT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Retrospective, observational case series. Patients with VMT who elected to proceed with CE, before any vitreoretinal intervention, were studied. Eyes with at least a 12-month follow-up period were included. The status of the vitreomacular adhesion at different time points was assessed using spectral-domain optical coherence tomography. The best-corrected visual acuity was recorded at different time points. Other macular and systemic comorbidities were documented.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fifteen eyes from 15 phakic patients with symptomatic VMT were included. Six of them were male subjects. Seven patients had diabetes mellitus and two of them also had nonproliferative diabetic retinopathy. The preoperative macular comorbidities included macular hole in six eyes (Stage 1 in 3 eyes and Stage 2 or 3 in another 3 eyes), epiretinal membrane in five eyes, and cystoid macular edema in four eyes. After uncomplicated CE, the VMT was released in 5 eyes, whereas in 10 eyes, CE did not significantly change the status of the vitreomacular adhesion. Three of 3 eyes with preexisting full-thickness macular hole (Stage 2 or 3 macular hole) were found to have Stage 4 macular hole shortly after CE. In seven of seven patients with diabetes mellitus, the status of the vitreomacular interface did not change after CE. Eventually, 7 of 15 patients underwent additional pars plana vitrectomy. Compared with the baseline vision, and vision before other interventions, the visual acuity after CE improved in 5 patients, remained unchanged in 7 patients, and decreased in the 3 patients with Stage 2 or 3 macular hole. The mean preoperative and early postoperative visual acuity was 20\/59 and 20\/68, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic> &gt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The effect of CE in phakic eyes with known VMT varies significantly. In the current case series, every eye with VMT and Stage 2 or 3 macular hole ended up with Stage 4 macular hole, although the VMT did not change significantly in the eyes of diabetic patients. Studies with larger sample size are needed to further elucidate the impact of elective CE on VMT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000002785","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T17:12:17Z","timestamp":1582823537000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["THE EFFECT OF ELECTIVE CATARACT EXTRACTION BY PHACOEMULSIFICATION IN EYES WITH VITREOMACULAR TRACTION SYNDROME"],"prefix":"10.1097","volume":"41","author":[{"given":"Dimosthenis","family":"Mantopoulos","sequence":"first","affiliation":[{"name":"NJ Retina, Rutgers- Robert Wood Johnson Medical School, New Brunswick, New Jersey;"},{"name":"Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Prenner","sequence":"additional","affiliation":[{"name":"NJ Retina, Rutgers- Robert Wood Johnson Medical School, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal K.","family":"Patel","sequence":"additional","affiliation":[{"name":"NJ Retina, Rutgers- Robert Wood Johnson Medical School, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Roth","sequence":"additional","affiliation":[{"name":"NJ Retina, Rutgers- Robert Wood Johnson Medical School, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit P.","family":"Shah","sequence":"additional","affiliation":[{"name":"NJ Retina, Rutgers- Robert Wood Johnson Medical School, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onoufrios","family":"Tsavaris","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Athens, Attikon University Hospital, Athens, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard F.","family":"Fine","sequence":"additional","affiliation":[{"name":"NJ Retina, Rutgers- Robert Wood Johnson Medical School, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Matthew","family":"Wheatley","sequence":"additional","affiliation":[{"name":"NJ Retina, Rutgers- Robert Wood Johnson Medical School, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":"Optical coherence tomography","volume":"254","author":"Huang","year":"1991","journal-title":"Science"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","article-title":"The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole","volume":"120","author":"Duker","year":"2013","journal-title":"Ophthalmology"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1097\/IAE.0000000000001792","article-title":"Prevalence of vitreomacular adhesion in patients without maculopathy older than 40 years","volume":"38","author":"Rodman","year":"2018","journal-title":"Retina"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/OPTH.S188704","article-title":"Incidence and prevalence of vitreomacular traction with and without macular hole in Germany","volume":"13","author":"Menzler","year":"2019","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.oret.2016.09.006","article-title":"The Charles Schepens Lecture: management options for vitreomacular traction: use an individualized approach","volume":"1","author":"Flynn","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1097\/IAE.0000000000001448","article-title":"Pneumatic vitreolysis for relief of vitreomacular traction","volume":"37","author":"Chan","year":"2017","journal-title":"Retina"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.2174\/1381612825666190124102148","article-title":"Pharmacotherapy of vitreomacular traction","volume":"24","author":"Wan","year":"2018","journal-title":"Curr Pharm Des"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/IAE.0000000000001760","article-title":"Predictive factors of visual outcome for vitreomacular traction syndrome after vitrectomy","volume":"38","author":"Yang","year":"2018","journal-title":"Retina"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5301\/EJO.2010.521","article-title":"Cataract-related acute vitreomacular traction syndrome","volume":"21","author":"Panagiotidis","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"R11-20250607","first-page":"1437","article-title":"Macular hole formation in a patient with Irvine-Gass syndrome: coincidence or rare complication?","volume":"7","author":"Moschos","year":"2013","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0002-9394(70)91041-X","article-title":"Vitreomacular traction syndrome confirmed histologically","volume":"69","author":"Reese","year":"1970","journal-title":"Am J Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archopht.1988.01060130678025","article-title":"Vitrectomy for macular traction caused by incomplete vitreous separation","volume":"106","author":"Smiddy","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/IAE.0000000000001012","article-title":"Electronic medical record database study of vitrectomy and observation for vitreomacular traction","volume":"36","author":"Jackson","year":"2016","journal-title":"Retina"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ajoc.2019.02.006","article-title":"Focal vitreomacular traction: resolution after ocular massage","volume":"14","author":"Garc\u00eda-Medina","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.ophtha.2009.03.051","article-title":"Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial","volume":"116","author":"de Smet","year":"2009","journal-title":"Ophthalmology"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0161-6420(95)30958-X","article-title":"Treatment of idiopathic macular holes by induced posterior vitreous detachment","volume":"102","author":"Chan","year":"1995","journal-title":"Ophthalmology"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1097\/IAE.0b013e3182a6b3e2","article-title":"Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy","volume":"33","author":"Jackson","year":"2013","journal-title":"Retina"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/sj.eye.6702587","article-title":"An unusual maculopathy after routine cataract surgery","volume":"21","author":"Costen","year":"2007","journal-title":"Eye"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1097\/IAE.0000000000002298","article-title":"Preoperative vitreoretinal interface abnormalities on spectral domain optical coherence tomography as risk factor for pseudophakic cystoid macular edema after phacoemulsification","volume":"39","author":"Copete","year":"2019","journal-title":"Retina"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/IAE.0000000000001228","article-title":"Diabetes alters the magnitude of vitreomacular adhesion","volume":"37","author":"Nesmith","year":"2017","journal-title":"Retina"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/S0161-6420(95)30788-9","article-title":"Baseline characteristics, natural history, and risk factors to progression in eyes with stage 2 macular holes. Results from a prospective randomized clinical trial. Vitrectomy for Macular Hole Study Group","volume":"102","author":"Kim","year":"1995","journal-title":"Ophthalmology"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9394(14)70214-4","article-title":"Prognosis of stage 2 macular holes","volume":"119","author":"Hikichi","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ophtha.2014.07.045","article-title":"Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials","volume":"122","author":"Haller","year":"2015","journal-title":"Ophthalmology"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2016.06.043","article-title":"Results of the 2-year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial","volume":"123","author":"Dugel","year":"2016","journal-title":"Ophthalmology"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40123-016-0062-6","article-title":"Ocriplasmin for treatment of vitreomacular traction: an update","volume":"5","author":"Khan","year":"2016","journal-title":"Ophthalmol Ther"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/IAE.0b013e3182a15f8b","article-title":"Clinical course of vitreomacular adhesion managed by initial observation","volume":"34","author":"John","year":"2014","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T20:00:42Z","timestamp":1749326442000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000002785","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,26]]}}}